Notice2022-10379
Agency Forms Undergoing Paperwork Reduction Act Review
Primary source
Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.
Published
May 13, 2022
Issuing agencies
Health and Human Services DepartmentCenters for Disease Control and Prevention
Full Text
<html>
<head>
<title>Federal Register, Volume 87 Issue 93 (Friday, May 13, 2022)</title>
</head>
<body><pre>
[Federal Register Volume 87, Number 93 (Friday, May 13, 2022)]
[Notices]
[Pages 29320-29321]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2022-10379]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[30Day-22-0469]
Agency Forms Undergoing Paperwork Reduction Act Review
In accordance with the Paperwork Reduction Act of 1995, the Centers
for Disease Control and Prevention (CDC) has submitted the information
collection request titled ``National Program of Cancer Registries
Cancer Surveillance System'' to the Office of Management and Budget
(OMB) for review and approval. CDC previously published a ``Proposed
Data Collection Submitted for Public Comment and Recommendations''
notice on November 22, 2021 to obtain comments from the public and
affected agencies. CDC received one non-substantive comment related to
the previous notice. This notice serves to allow an additional 30 days
for public and affected agency comments.
CDC will accept all comments for this proposed information
collection project. The Office of Management and Budget is particularly
interested in comments that:
(a) Evaluate whether the proposed collection of information is
necessary for the proper performance of the functions of the agency,
including whether the information will have practical utility;
(b) Evaluate the accuracy of the agencies estimate of the burden of
the proposed collection of information, including the validity of the
methodology and assumptions used;
(c) Enhance the quality, utility, and clarity of the information to
be collected;
(d) Minimize the burden of the collection of information on those
who are to respond, including, through the use of appropriate
automated, electronic, mechanical, or other technological collection
techniques or other forms of information technology, e.g., permitting
electronic submission of responses; and
(e) Assess information collection costs.
To request additional information on the proposed project or to
obtain a copy of the information collection plan and instruments, call
(404) 639-7570. Comments and recommendations for the proposed
information collection should be sent within 30 days of publication of
this notice to <a href="http://www.reginfo.gov/public/do/PRAMain">www.reginfo.gov/public/do/PRAMain</a>. Find this particular
information collection by selecting ``Currently under 30-day Review--
Open for Public Comments'' or by using the search function. Direct
written comments and/or suggestions regarding the items contained in
this notice to the Attention: CDC Desk Officer, Office of Management
and Budget, 725 17th Street NW, Washington, DC 20503 or by fax to (202)
395-5806. Provide written comments within 30 days of notice
publication.
Proposed Project
National Program of Cancer Registries Cancer Surveillance System
(NPCR CSS) (OMB Control No. 0920-0469, Exp. 12/31/2022)--Revision--
National Center for Chronic Disease Prevention and Health Promotion
(NCCDPHP), Centers for Disease Control and Prevention (CDC).
Background and Brief Description
In 2018, the most recent year for which complete incidence
information is available, almost 600,000 people died of cancer and more
than 1.7 million were diagnosed with cancer. It is estimated that 16.3
million Americans are currently alive with a history of cancer. In the
U.S., state/territory-based central cancer registries are the only
method for systematically collecting and reporting population-based
information about cancer incidence and outcomes such as survival. These
data are used to measure the changing incidence and burden of each
cancer; identify populations at increased or increasing risk; target
preventive measures; and measure the success or failure of cancer
control efforts in the U.S.
In 1992, Congress passed the Cancer Registries Amendment Act which
established the National Program of Cancer Registries (NPCR). The NPCR
provides support for state/territory-based cancer registries that
collect, manage, and analyze data about cancer cases. The state/
territory-based cancer registries report information to CDC through the
National Program of Cancer Registries Cancer Surveillance System (NPCR
CSS) (OMB Control No. 0920-0469, Exp. 12/31/2022). CDC plans to request
OMB approval to continue collecting this information for three years.
Data definitions will be updated to reflect changes in national
standards for cancer diagnosis and coding. No changes to the total
estimated annualized burden hours or number of respondents are
anticipated.
The NPCR CSS allows CDC to collect, aggregate, evaluate, and
disseminate cancer incidence data at the national level. The NPCR CSS
is the primary source of information for the United States Cancer
Statistics (USCS), which CDC has published annually since 2002. The
latest USCS report published in 2021 provided cancer statistics for 99%
of the U.S. population from cancer registries in the United States.
Prior to the publication of USCS, cancer incidence data at the national
level were available for only 14% of the population of the United
States.
The NPCR CSS also allows CDC to monitor cancer trends over time,
describe geographic variation in cancer incidence throughout the
country, and
[[Page 29321]]
provide incidence data on racial/ethnic populations and rare cancers.
These activities and analyses further support CDC's planning and
evaluation efforts for state and national cancer control and
prevention. In addition, datasets can be made available for secondary
analysis.
Respondents are NPCR-supported central cancer registries (CCR) in
46 U.S. states, 3 territories, and the District of Columbia. Fifty CCRs
submit data elements specified for the Standard NPCR CSS Report. Each
CCR is asked to transmit two data files to CDC per year. The first NPCR
CSS Standard file, submitted in January, is a preliminary report
consisting of one year of data for the most recent year available. CDC
evaluates the preliminary data for completeness and quality and
provides a report back to the CCR. The second NPCR CSS Standard file,
submitted by November, contains cumulative cancer incidence data from
the first diagnosis year for which the cancer registry collected data
with the assistance of NPCR funds (e.g., 1995) through 12 months past
the close of the most recent diagnosis year (e.g., 2018). The
cumulative file is used for analysis and reporting.
The burden for each file transmission is estimated at two hours per
response. Because cancer incidence data are already collected and
aggregated at the state level, the additional burden of reporting the
information to CDC is small. All information is transmitted to CDC
electronically. CDC requests OMB approval for an estimated 200 annual
burden hours. Participation is required as a condition of the
cooperative agreement with CDC. There are no costs to respondents other
than their time.
Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Average
Number of Number of burden per
Type of respondents Form name respondents responses per response (in
respondent hours)
----------------------------------------------------------------------------------------------------------------
Central Cancer Registries in States, Standard NPCR CSS Report 50 2 2
Territories, and the District of
Columbia.
----------------------------------------------------------------------------------------------------------------
Jeffrey M. Zirger,
Lead, Information Collection Review Office, Office of Scientific
Integrity, Office of Science, Centers for Disease Control and
Prevention.
[FR Doc. 2022-10379 Filed 5-12-22; 8:45 am]
BILLING CODE 4163-18-P
</pre></body>
</html>Indexed from Federal Register on May 13, 2022.
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.